Device and method for 3D cell culture in a well
Patent Information
- Application Number
- PCT/US2024/029858
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-17
- Filing Date
- 2024-05-17
- Publication Date
- 2024-11-21
Smart Images

Figure US2024029858_21112024_PF_FP_ABST
Abstract
Description
DEVICE AND METHOD FOR 3D CELL CULTURE IN A WELLCROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This Application claims priority to U.S. Provisional Patent Application No. 63 / 467,060, titled “Device and Method for 3D Cell Culture in a Well,” filed on May 17, 2023, the entire disclosure of which are incorporated herein by reference.FIELD
[0002] This disclosure relates to cell biology and / or tissue engineering, and more particularly, to systems and methods for mimicking a three-dimensional biological environment during cell-culture applications using a three-dimensional scaffold inserted into a culture well of a culture plate.BACKGROUND
[0003] Recent drug discovery efforts have focused on incorporating in vitro cell models that better mimic the in vivo conditions found within a target patient Conventionally, a predetermined quantity or concentration of model cells is seeded onto a coated microplate well. The microplate is incubated to encourage the cells to attach in a two-dimensional (2D) monolayer before performing a prescribed assay. While this may provide some improvements over biochemical and immortalized cell lines, culturing cells in this 2D manner may be problematic, at least because 2D cell-culture models typically do not accurately model in vivo environmental conditions and / or cellular behaviors.
[0004] For example, studies of 2D cell-culture models have shown that attrition rates of drag candidates for cancer can be as high as approximately 95%. Further, in vitro drug efficacy values can fail to translate to clinical environments. Still further, unforeseen toxicity issues can arise. First, it is believed that in 2D Cell-culture models, some extracellular matrix (ECM) components are missing, and therefore, certain cell-to-cell and cell-to-matrix interactions do not occur. These components and interactions are critical to cell differentiation, cell proliferation, and / or cellular function that normally occur in vivo. Second, it has been found that the environment of a 2D cell-culture model may not accurately mimic a three-dimensional (3D) in vivoenvironment where cancer cells reside, because the 2D environment does not allow for areas of hypoxia, heterogeneous cell populations, varying cell proliferation zones, ECM influences, soluble signal gradients, and / or differential nutrient and metabolic waste transport.
[0005] 3D cell-culture models may be utilized to overcome many limitations of 2D cell- culture models because 3D cell-culture models more closely mimic the features and environments of complex in vivo conditions. For example, studies have shown that tumor cells of specific cell lines, evaluated using 3D cell-culture models, are less sensitive to anti-cancer agents than when the same tumor cells are cultured using 2D cell-culture models.
[0006] As the cell model moves from 2D to 3D, not only do cell interactions and expressions change dramatically, but also the kinetics of cellular metabolism varies. A fundamental challenge is to deliver the metabolites to the cells deep inside a bigger model (e.g., greater than 1 mm on an edge) and to transport waste and proteins out of the model. Hence, a passage for metabolites to travel in and out of a large-scale model is desired, for example, for a model having pumped internal perfusion passages.
[0007] One way to build 3D cell-culture models is to form 3D scaffolds out of porous polymeric and / or biologic materials. At least one study determined an optimal pore size (e.g., pore diameter) for 3D scaffolds of cell-culture models of approximately 100-400 μm. See Han, et. al, “Effect of Pore Size on Cell Behavior Using Melt Electrowritten Scaffolds,” Frontiers in Bioengineering and Biotechnology, Volume 9, Article 629270, July 2021. This result was based on achieving good cell nutrition, cell-growth space, and cell-scaffold interaction (the result depended on the specific cell lines).
[0008] Consistently controlling the size and shape of pores to achieve repeatable results requires a high precision manufacturing method. For example, to consistently create pores with diameters of 100 μm typically requires a manufacturing method having sub-20 μm resolution, such as micro 3D printing. In particular, projection micro stereolithography (PμSL) and two-photon polymerization are micro 3D printing techniques are capable of consistently creating complex 3D structures. Further, these printing techniques can create 3D structures from biocompatible and / or biodegradable polymers, such as poly-ethylene glycol (PEG) and poly lactic acid (PI.A). After polymerization, these polymers may be hard (e.g., greater than 1 GPa elastic modulus) or soft (e.g., less than 1 MPa elastic modulus).
[0009] Cell cultures can be described in terms of reaction kinetics. In steady state, the process of cells consuming metabolites (e.g,, cell nutrients) is often described by the Michaelis- Menten equation:where v is the velocity of the reaction, Vmaxis the maximum uptake rate of metabolites, KMis the metabolite concentration when the uptake rate is half of the maximum (the Michaelis constant), and [S] is the concentration of metabolites. In Michaelis-Menten kinetics, the consumption behavior follows first order kinetics at low concentration. This means the consumption rate is proportional to the concentration. As the concentration of the metabolite increases, the consumption behavior will gradually become zero order kinetics. This means the consumption rate is near or equal to the maximum velocity and is independent of metabolite concentration. This is because the cells eventually become saturated and therefore their intake of metabolites reaches a plateau.
[0010] Metabolites are depleted as they transport through a cell cluster / tissue. The consumption rate decreases approximately parabolically. In an in vivo environment, when the cell concentration is on the order of 109cells / ml, the cells stay less than 100 μm from blood capillaries. It is therefore advantageous for cells to stay within the zone that the nutrient concentration is higher than KM, (the metabolite concentration when the uptake rate is half of the maximum). It has been shown that at a high cell density, for 10 μm capillary tube wall thickness with metabolite diffusivity of 10-9cm2 / s, the nutrient concentration decreases over 80% after going through the wall of the tube. See Xia, “3D Microfabricated Bioreactor with Capillaries,” Biomedical Microdevices 11(6): 1309-1315, October 2009. Hence, the perfusion culture media will need higher concentration than in traditional 2D direct media contact culture. To save on the cost of media, especially in high throughput mass drug screening processes, a higher density of nutrient transport passages (e.g., capillaries), that can support medias of lower concentration, can be utilized to emulate a higher media concentration.
[0011] At the early stage of a new drug development, tens of thousands of compounds are screened. This process typically requires a high throughput method for compound screening. In current 2D cell-culture methods, typically 96-well or 384-well culture plates are utilized. Hence any new 3D cell-culture model should not only be more accurate than current 2D methods, but it should be able to accommodate high throughput processes for screening large amounts of potentialchemical compounds for targeted treatment effects. However, current 3D perfusion models lack such high throughput capability due in part to physical size limitations and issues with system integration. Embodiments of the disclosed invention overcome several of the above-described limitations.SUMMARY
[0012] The disclosed embodiments provide for a passive perfusion well insert (e.g., a scaffold not coupled to an active pump), for a 3D cell culture, having metabolite transport passages and micro pores to promote 3D cell-to-cell and cell-to-matrix interactions, and at the same time to promote the transport of metabolites and metabolic waste for high-cell-density 3D cell cultures, where no external pump is required. In some embodiments, the well inserts conform to the dimensions of the wells in standard multi-well culture plates, thereby providing a high throughput system that is compatible with practically any multi-well culture plate. Such a perfusion Well insert (scaffold) can better mimic the real biological environment of cells in vi vo, which is critical for an accurate drug screening, without sacrificing the high throughput of traditional 2D culture plate screening.
[0013] In one embodiment, the scaffold includes: a flange, or sealing skirt, circumscribing a lower portion of the scaffold; and a plurality of vertically oriented cell-cuhure chambers horizontally separated by one or more culture-media regions; wherein each cell-culture chamber is defined by; a top wall having at least one vent bole, at least one side wall having a plurality of pores, and an opening at a bottom portion thereof; and each culture-media region is closed at a bottom portion thereof and open at a top portion thereof.BRIEF DESCRIPTION OF THE DRAWINGS
[0014] A more complete appreciation of the present disclosure and many of the attendant advantages thereof will be readily obtained as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings.
[0015] FIG. 1 shows a perspective view of an exemplary 3D culture-well insert.
[0016] FIG. 2 shows a cross-sectional view of the 3D culture-well insert of FIG. 1 taken along line A-A.
[0017] FIG. 3 shows a plurality of 3D culture-well inserts each aligned with a culture well of a culture well plate.
[0018] FIG. 4 shows part of a cross-sectional view of the 3D culture-well inserts and culture plate of FIG. 3 taken along line B-B.
[0019] FIG. 5 shows an exemplary sequence of inserting a 3D culture-well insert into a culture well that is partially filled with a mixture of cells and hydrogel and then adding a culture media 320 to the culture well.
[0020] FIG. 6 shows an exemplary 3D culture-well insert within a culture well during a cell-culture application.DETAILED DESCRIPTION
[0021] The present disclosure may be more readily understood by reference to the following detailed description and the accompanying drawings, which form a part of this disclosure. This disclosure is not limited to the specific devices, methods, conditions, or parameters described and / or shown herein, and the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of disclosed embodiments or inventions. For example, “left,” “right,” “clockwise,” and “counterclockwise” may be used as specific examples of generally opposite lateral or rotational directions, respectively. Also, as used in the specification and including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise.
[0022] The following numerals are used to describe various features of the embodiments.100 3D culture-well insert (abbreviated as “insert”)110 cell-culture chamber120 culture-media region130 sealing skirt140 vent hole150 transport pore160 cell-culture chamber fin width170 cell-culture chamber separation180 wall190 wall thickness200 culture plate210 culture well300 cell310 hydrogel320 culture media330 metabolite
[0023] There are a few types of cell-culture plates available in the biomedical industry that vary based on a quantity and configuration of wells therein, for example 6-well, 12-well, 24-well, 48-well, 96-well, 384-well, and so on. For high-throughput screening, the industry currently tends to use 96-well or 384-well culture plates or larger. Culture plates can be further divided by the shape of the well, such as flat-bottom, round-bottom, V-bottom, and so on. While the disclosed invention covers any size and shape of culture plate, the embodiments described herein focus on an exemplary 96-well flat-bottom plate for simplicity.
[0024] FIG. 1 shows a 3D well insert 100 comprising a plurality of cell-culture chambers 110 configured and arranged as concentric cylindrical annuli (where an annulus is a ring-shaped region between two concentric circles), which may also be described as concentric cylindrical shells, concentric tube-shaped chambers, concentric cavities, and so on, and FIG. 2 shows a cross section of the insert 100 taken along line A-A of FIG. 1. The overall cylindrical shape of the insert 100 (and its regions in some embodiments) is to mimic, or conform to, a cylindrical shape of a typical culture well 210 of a culture plate 200 (as shown in FIGS. 3-6 and described later), butother shapes are contemplated to match differently shaped culture wells, such as concentric cuboids (e.g., hollow rectangular horizontal cross-sections). Further, instead of concentric cylindrical annuli or concentric hollow cuboids, the cell-culture chambers 110 may be defined by any suitable hollow three-dimensional shape, such as walls (curved or straight), columns, rods, or tubes, that protrude into one or more culture-media regions 120, and which may be arranged in any suitable pattern, such as in rows, star patterns, concentric circles, concentric rectangles, random, and so on.
[0025] In the illustrated embodiment, there are two types of volumes (e.g., chambers or regions): cell-culture chambers 110 and culture-media regions 120. FIGS. 1 -2 show six cell-culture chambers 110 and six culture-media regions 120, but these quantities may vary based on certain factors, such as a diameter of a culture well 210. Note that in some embodiments comprising concentric cell-culture chambers 110, an outermost culture-media region 120 may comprise a wall 180 on only one vertical side thereof, where a sidewall of a culture well 210 bounds the outermost side of the outermost culture-media region 120 (as shown in FIGS. 4-6 and described later herein).
[0026] Each cell-culture chamber 110 is open, or unsealed, at a bottom portion of the insert100 to permit a mixture of cells, extracellular matrix, and / or hydrogel to be pushed, forced, or squeezed into the cell-culture chamber 110 during insertion of the insert 100 into a culture well 210 as described later herein with reference to FIG. 5. Each cell-culture chamber 110 is closed, or sealed, at a top portion of the insert 100, notwithstanding one or more vent holes 140 at the top portion thereof to aid in removal of air and / or other gases during insertion of the insert 100 into a culture well 210. In some embodiments, the diameter of each vent hole 140 may be 20 μm.
[0027] Each culture-media region 120 is substantially closed, or sealed, at a bottom portion of the insert 100 by the wall 180 (or by the sealing skin 130 in the case of some embodiments comprising concentric cell-culture chambers 110 and having an outermost culture-media region 120) to prevent an excessive amount of the mixture of cells, extracellular matrix, and / or hydrogel to be pushed, forced, or squeezed into the culture-media region 120 during insertion of the insert 100 into a culture well 210 as described later herein with reference to FIG. 5. For simplicity, the bottom of a culture-media region 120 may be referred to herein as a “wall” regardless of whether it is formed by the wall 180, by the sealing skirt 130, or by any other suitable element
[0028] Each culture-media region 120 is open, or unsealed, at a top portion of the insert 100 to aid in a transport of metabolites and metabolic waste in and out of the insert 100 as described later herein with reference to FIG. 6.
[0029] to some embodiments, an inner width 160 of a fin of each cell-culture chamber 110 is 0.20 mm, and a separation 170 between each fin of adjacent cell-culture chambers 110 is 0.32 mm. In some embodiments, the wall thickness 190 of the walls 180 of the insert 100 is 10-50 μm (which walls 180 bound the cell-culture chambers 110 and the culture-media regions 120, notwithstanding the outermost culture-media region 120 as indicated earlier herein), such that an outer diameter of the outermost cell-culture chamber 110 may be 5.84 mm (e.g., 0.20 mm * 11 fins + 0.32 mm * 10 separations + 0.02 mm * 22 walls ~ 5.84 mm). Some or all of these dimensions may vary based on certain factors, such as a diameter of a culture well 210, diffusion coefficients of certain metabolites, and / or a desired amount of structural strength of the insert 100. For example, the wall thickness 190 may be based on a thickness that is necessary for damage-free insertion of the insert 100 into a culture well 210, with consideration for mechanical properties of a material or materials used to construct the walls 180, where such material or materials may be any suitable material such as an aforementioned biocompatible and / or biodegradable polymer like PEG or Pl. A. In some embodiments, the fin widths 160 may vary among the plurality of cell-culture chambers 110, and the separations 170 may vary among the plurality of culture-media regions 120. Further, the wall thickness 190 may vary at different locations of the insert 100.
[0030] The insert 100 shown in FIGS. 1-2 includes a flange, or sealing skirt 130, circumscribing a lower portion of the outermost cell-culture chamber 110. An outer diameter of the sealing skirt 130 may be substantially equal to an inner diameter of a bottom portion of a culture well 210, to prevent an undesired amount of a mixture of cells, extracellular matrix, and / or hydrogel from entering the outermost culture-media region 120 according to the following explanation with reference to FIGS. 3-5. The outer diameter of the sealing skirt 130 is intended to describe the dimension or dimensions across an outline of a perimeter of the sealing skirt 130 for any shape of the outline, such as circular, square, rectangular, and so on.
[0031] FIG. 3 shows a plurality of inserts 100 aligned with a plurality of culture wells 210 of a culture plate 200, and FIG. 4 shows a portion of a cross-sectional view of the culture plate 200, taken along line B-B, comprising several culture wells 210 and inserts 100 inserted therein. FIG. 5 shows a process of inserting an insert 100 into a culture well 210 in preparation for a cell-culture application. As shown in the upper left illustration, the culture well 210 is partially filled with a predetermined amount of a mixture of cells 300 and hydrogel 310. As shown in the lower left illustration, the insert 100 enters an upper portion of the culture well 210 and is lowered toward and onto the mixture of cells 300 and hydrogel 310. As shown in the lower right illustration, the insert 100 is pushed further towards the bottom of the culture well 210, causing the mixture of cells 300 and hydrogel 310 to enter into and be forced up the cell-culture chambers 110, during which air and other gases may be allowed to escape through the vent holes 140 and possibly the transport pores 150. The predetermined amount of the mixture of cells 300 and hydrogel 310 may completely fill the cell-culture chambers 110 without overflowing when the insert 100 is fully seated in the culture well 210.
[0032] In some embodiments, the outer diameter of the sealing skirt 130 may be approximately equal to the inner diameter of the culture well 210 near or at the bottom thereof, such that very little or none of the mixture of cells 300 and hydrogel 310 is able to enter the outermost culture-media region 120. In other embodiments, there may be a gap, for example 50 μm, between the outer edge of the sealing skirt 130 and the inside of the culture well 210, allowing some of the mixture of cells 300 and hydrogel 310 to enter the outermost culture-media region 120. In still other embodiments, the outer diameter of the sealing skirt 130 may be larger than the inside diameter of the culture well, for example by 10 ~ 20 μm, to create a mechanical friction that may be beneficial to prevent a relatively low-density insert 100 from becoming buoyant when immersed in a relatively high-density culture media 320. Floating of an insert 100 may cause difficulties with metrological and image analyses during or after cell-culture applications.
[0033] The upper right illustration of FIG. 5 shows the culture media 320 added to the culture well 210. on top of the properly seated insert 100, such that the culture media 320 enters and fills the culture-media regions 120. In some embodiments, the culture media 320 should be added within five minutes of seating the insert 100 into the culture well 210 that is partially filled with the mixture of cells 300 and hydrogel 310. In some embodiments, a top of the insert 100 should not be immersed under more than 5 mm of culture media 320 (i.e., a top level of culture media 320 should be at most 5 mm above a top of the seated insert 100).
[0034] The insert 100 may be used in cell-culture applications at a temperature that is similar to that of living tissue, for example, average human body temperattire of approximately 37 degrees Celsius (98.6 degrees Fahrenheit). At this temperature, the diffusion coefficient ofmetabolites in tissue or a culture media 320 is approximately 10-5to 10-6cm2 / s, which is significantly greater than in the respective diffusion coefficient of such metabolites in a biocompatible and / or biodegradable polymer like PEG or PL A of approximately 10-9to 10-10cm2 / s (i.e.. such metabolites diffuse significantly more slowly in the biocompatible and / or biodegradable polymer than in tissue or culture media 320). Thus, several embodiments of the invention include transport pores 150 in the walls 180 separating the cell-culture chambers 110 from the culture- media regions 120. These transport pores 150 may have diameters that permit certain metabolites to travel therethrough and to prohibit certain cells from traveling therethrough. In some embodiments, the diameter of each transport pore 150 may be approximately 10 μm. Such diameter may help to promote fast tissue growth within the insert 100 during cell-culture applications, for example, to achieve sufficient tissue growth within 14 days.
[0035] In cell-culture applications where no external pump is used to force culture media 320 to flow into and / or through a cultured tissue, diffusion is a primary mechanism for the transport of metabolites. A characteristic length of metabolite transport may be determined by diffusion kinetics. Specifically, Fick’s law may be used to describe this characteristic length:where t is a time period, D is the diffusion coefficient, and L is the distance traveled by diffusion in the time period t.
[0036] One of the most important metabolites in cell-culture applications is oxygen. A ceil that fails to receive a sufficient and timely supply of oxygen may suffer hypoxia and may die as a result. As an estimate, a tissue cell can survive without oxygen for approximately five minutes. For embodiments of the invention where no external pump is used, the transport of oxygen relies primarily on difiusion diftusion through the walls 180 via the transport pores 150 (from the culture-media regions 120 io the cell-culture chambers 110), and diffusion into the cultured tissue (within the cell-culture chambers 110).
[0037] The diffusion coefficient of oxygen in tissue is approximately 10-6cm2 / s. Using Fick’s law, oxygen diffuses in tissue approximately 0.17 mm in five minutes (e.g., This is one factor consideredin determining the width 160 of each fin of the cell-culture chambers 110, according to the following explanation. As shown in FIGS. 1-2, each cell-culture chamber 110 is flanked and surrounded on either lateral side by a culture-media region 120. The culture-media regions 120may be filled with oxygen-rich culture media 320 (as described earlier). Oxygen present in the culture-media regions 120 may diffuse into the cell-culture chambers 110, from either side thereof, by a distance of approximately 0.17 mm within five minutes. Thus, an inner width 160 of each fin of the cell-culture chambers 110 that is equal to 0.20 mm means that oxygen may readily diffuse, inward from each wall 180 of a cell-culture chamber 110, past a vertical midline of a fin of the cell-culture chamber 110 and nearly to the opposite wall 180 within 5 minutes (where the vertical midline is 0.20 mm / 2 = 0.10 mm from the wall 180). Using this same reasoning for preventing cell hypoxia, the distance between adjacent transport pores 150 may also be set equal to approximately 0.20 mm. Note that the diffusion time of oxygen through the relatively thin wall 180 is relatively negligible, e.g., for a 0.02 mm wall thickness 190, it takes approximately 4.0 seconds to diffuse through a transport pore 150 (e.g., solving Fick’s law for i, t = where the diffusion coefficient of oxygen in thehydrogel 310 within a transport pore 150 is approximately 10-6cm2 / s,
[0038] As described earlier and as shown in the upper right illustration of FIG. 5, a metabolite-rich culture media 320 may be poured onto the insert 100 within a culture well 210. The metabolites 330 in the culture media 320 may enter each culture-media region 120 and diffuse downward therein toward the bottoms thereof, and such metabolites may diffuse through any of the transport pores 150 into the cell-culture chambers 110 to be consumed by cells 300. Diffusion of metabolites 330 down a culture-media region 120 takes a finite amount of time; thus, cells 300 located at or near die bottoms of the cell-culture chambers 110 (near or at the downward-facing openings thereof) may be among the last cells 300 to receive metabolites, such as oxygen. Thus, a depth of each culture-media region 120 for some embodiments may be ascertained based on a distance that oxygen may diffuse down each culture-media region 120 within five minutes (where five minutes is the earlier-indicated estimate of when cell hypoxia may occur) and application of basic conservation of mass, as explained below.
[0039] In some embodiments, the cross-sectional area of a culture-media region 120 is significantly greater than the cross-sectional area of the transport pores 150, for example by at least a factor of 50. Thus, there may be at least 50 times the amount of oxygen diffusing down a culture- media region 120) as there is diffusing through a transport pore 150 (during steady state). This means the required diffusion time for oxygen to reach the bottom of a culture-media region 120 may be relaxed by a factor of 50 (or more), from five minutes to 5 * 5500 = 250 minutes.Consequently, a maximum depth of a culture-media region 120 may be computed using Fick’s law conservative, insome embodiments, the depth may be set to 2.0 mm, which is less than 3.9 mm. Note that the factor of 50 difference between the cross-sectional area of a culture-media region 120 and the cross-sectional area of the transport pores 150 is also a conservative estimate in some embodiments. For example, in aft embodiment where the separation 170 is 0.32 mtn and transport pores 150 are spaced 0.20 mm apart, a unit cross-sectional area can be defined as approximately (0.32 mm * 0.20 mm) « 0.064 mnr (64000 μm2), where such unit area is associated with two transport pores 150 (one on either side of the wall 180 bounding the culture-media region 120). In an embodiment where each transport pore 150 has a diameter of 10 μm, the cross-sectional area of a transport pore 150 is approximately πr2= π (10μm / 2)2= 78.5 μm2. Thus, the ratio of one unit cross-sectional area of culture-media region 120 to two transport pores 150 is 64000 μm2 / (2 * 78.5 μm2) == 408 ≃ 400, which is much greater than the factor of 50 used in determining a depth of a culture-media region 120 above (using a factor of 50 is more conservative than using a factor of approximately 400).
[0040] During a Cell-culture application, a culture plate 200 as shown in FIG. 3, comprising one or more culture wells 210 prepared as shown in FIG. 6, may be placed in an incubator that controls certain environmental conditions such as temperature, humidity, and carbon dioxide levels. FIG. 6 shows a prepared culture well 210, comprising an insert 100 seated or resting at the bottom of the culture well 210. The cell-culture chambers 110 are filled with a mixture of cells 300 and hydrogel 310 as explained earlier, and the insert 100 is immersed in a bath of culture media 320 as explained earlier. Dashed arrows show the diffusion of metabolites 330 (and metabolic waste) within the culture-media regions 120. As the cells 300 consume the metabolites 330 and produce metabolic waste, the culture media 320 may need to be replaced or replenished.
[0041] Some implementations of 3D cell culture in a well disclosed herein include a scaffold, comprising: a flange circumscribing a lower portion of the scaffold; and a plurality of vertically oriented chambers horizontally separated by one or more culture-media regions; wherein each chamber comprises: a top wall having at least one vent hole, at least one side wall having a plurality of pores, and an opening at a bottom portion thereof; and each culture-media region is closed at a bottom portion thereof and open at a top portion thereof.
[0042] In some implementations, the walls defining each chamber have a thickness of approximately 10-50 μm.
[0043] In some implementations, each pore has a diameter of approximately 10 μm.
[0044] to some implementations, adjacent pores of the plurality of pores of a respective side wall are separated by approximately 0.20 + / - 0.10 mm.
[0045] In some implementations, a horizontal inner width between respective sidewalls of a respective chamber is approximately 0.20 + / - 0.10 mm.
[0046] In some implementations, a horizontal separation between adjacent chambers is approximately 0.32 + / - 0.10 mm.
[0047] In some implementations, a vertical height of a respective chamber is approximately 2.0 + / - 1.0 mm.
[0048] In some implementations, the plurality of chambers comprises a plurality of concentric cylindrical annuli.
[0049] In some implementations, the plurality of chambers comprises a plurality of one or more of: Concentric or non-concentric complete or partial cylindrical annuli; concentric or non- concentric complete or partial cylindrical hollow cuboids; curved or straight hollow walls; and hollow columns.
[0050] to some implementations, an outline of a perimeter of the flange mimics an outline of a horizontal cross section of a bottom portion of a culture well
[0051] In some implementations, there is a gap of approximately 0-50 μm between the outline of the perimeter and the outline of the horizontal cross section.
[0052] In some implementations, the outline of the perimeter extends approximately 10- 20 μm beyond the outline of the horizontal cross section.
[0053] In some implementations, an outer diameter of the flange is approximately 10-20 μm greater than an inner diameter of a bottom portion of a culture well.
[0054] Some implementations of 3D cell culture in a well disclosed herein include a method of using a scaffold, comprising: inserting the scaffold toward a bottom of a culture well that is at least partially filled with a mixture of cells and hydrogel so that the mixture enters and fills the chambers; and adding a culture media to the culture well to submerge the scaffold and to fill the culture-media regions; wherein the scaffold comprises: a flange circumscribing a lower portion of the scaffold; and a plurality of vertically oriented chambers horizontally separated byone or more culture-media regions; wherein each chamber comprises: a top wall having at least one vent hole, at least one side wall having a plurality of pores, and an opening at a bottom portion thereof; and each culture-media region is closed at a bottom portion thereof and open at a top portion thereof.
[0055] In some implementations, wherein the culture well, the scaffold, the mixture, and the culture media are placed in an incubator that controls at least one of temperature, humidity, and carbon dioxide levels.
[0056] In some implementations, wherein at least a portion of the culture media is periodically replaced.
[0057] Some implementations of 3D cell culture in a well disclosed herein include a method of using a scaffold, comprising: inserting each scaffold toward a bottom of a respective culture well of a culture plate, where the respective culture well is at least partially filled with a respective mixture of cells and hydrogel so that the respective mixture enters and fills the chambers of the respective scaffold; and adding a respective culture media to a respective culture well to submerge a respective scaffold and to fill the culture-media regions of the respective scaffold; wherein the scaffold comprises: a flange circumscribing a lower portion of the scaffold; and a plurality of vertically oriented chambers horizontally separated by one or more culture-media regions; wherein each chamber comprises: a top wall having at least one vent hole, at least one side wall having a plurality of pores, and an opening at a bottom portion thereof; and each culture- media region is closed at a bottom portion thereof and open at a top portion thereof.
[0058] In some implementations, the culture plate, the scaffolds, the mixtures, and the culture medias are placed in an incubator that controls at least one of temperature, humidity, and carbon dioxide levels.
[0059] In some implementations, at least a portion of at least one respective culture media is periodically replaced.
[0060] While several embodiments of the disclosure have been shown in the drawings, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments.
Claims
WHAT IS CLAIMED IS:
1. A scaffold for a three-dimensional cell culture, the scaffold comprising: a flange circumscribing a lower portion of the scaffold; and a plurality of vertically oriented chambers horizontally separated by one or more culture-media regions; wherein each chamber compriises: a top wall having at least one vent hole, at least one side wall having a plurality of pores, and an opening at a bottom portion thereof; and each culture-media region is closed at a bottom portion thereof and open at a top portion thereof.
2. The scaffold of claim 1 wherein the walls defining each chamber have a thickness of approximately 10-50 μm.
3. The scaffold of claim 1 wherein each pore has a diameter of approximately 10 μm.
4. The scaffold of claim 1 wherein adjacent pores of the plurality of pores of a respective side wall are separated by approximately 0.20 + / - 0.10 mm.
5. The scaffold of claim 1 wherein a horizontal inner width between respective sidewalls of a respective chamber is approximately 0.20 + / - 0.10 mm.
6. The scaffold of claim 1 wherein a horizontal separation between adjacent chambers is approximately 032 + / - 0.10 mm.
7. The scaffold of claim 1 wherein a vertical height of a respective chamber is approximately 2.0 4- / - 1.0 mm.
8. The scaffold of claim 1 wherein the plurality of chambers comprises a plurality of concentric cylindrical annuli.
9. The scaffold of claim 1 wherein the plurality of chambers comprises a plurality of one or more of: concentric or non-concentric complete or partial cylindrical annuli; concentric or non-concentric complete or partial cylindrical hollow cuboids; curved or straight hollow walls; and hollow columns.
10. The scaffold of claim 1 wherein an outline of a perimeter of the flange mimics an outline of a horizontal cross section of a bottom portion of a culture well.
11. The scaffold of claim 10 wherein there is a gap of approximately 0-50 μm between the outline of the perimeter and the outline of the horizontal cross section.
12. The scaffold of claim 10 wherein the outline of the perimeter extends approximately 10-20 μm beyond the outline of the horizontal cross section.
13. The scaffold of claim 1 wherein an outer diameter of the flange is approximately 10-20 μm greater than an inner diameter of a bottom portion of a culture well.
14. A method of using the scaffold of claim 1 to culture cells, the method comprising: inserting the scaffold toward a bottom of a culture well that is at least partially filled with a mixture of cells and hydrogel so that the mixture enters and fills the chambers; and adding a culture media to the culture well to submerge the scaffold and to fill the culture-media regions.
15. The method of claim 14 wherein the culture well, the scaffold, the mixture, and the culture media are placed in an incubator that controls at least one of temperature, humidity, and carbon dioxide levels.
16. The method of claim 15 wherein at least a portion of the culture media is periodically replaced.
17. A method of using a plurality of scaffolds of claim 1 to culture cells, the method comprising: inserting each scaffold toward a bottom of a respective culture well of a culture plate, where the respective culture well is at least partially filled with a respective mixture of cells and hydrogel so that the respective mixture enters and fills the chambers of the respective scaffold; and adding a respective culture media to a respective culture well to submerge a respective scaffold and to fill the culture-media regions of the respective scaffold.
18. The method of claim 17 wherein the culture plate, the scaffolds, the mixtures, and the culture medias are placed in an incubator that controls at least one of temperature, humidity, and carbon dioxide levels.
19. The method of claim 18 wherein at least a portion of at least one respective culture media is periodically replaced.
Citation Information
Patent Citations
Biological reaction system for long-term large-scale amplification of human umbilical cord mesenchymal stem cells
CN113736658A
Bio-scaffold
GB2605009A
Formation of arrays of planar intestinal crypts possessing a stem / proliferative cell compartment and differentiated cell zone
US20230098968A1
Cell culture device for culturing 3D cell aggregation and cell culture method using same
WO2022231310A1
